Platinum is essential in neoadjuvant treatment of triple negative breast cancer: A network meta-analysis

被引：0
|
作者：
Li, Junjie
Chen, Li
Tan, Wei
Qi, Fang
Zhang, Yang
Wang, Zhonghua
Shao, Zhimin
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-12-19
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-12-19
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis
    Rizzo, A.
    Schipilliti, F. M.
    Di Costanzo, F.
    Acquafredda, S.
    Arpino, G.
    Puglisi, F.
    Del Mastro, L.
    Montemurro, F.
    De Laurentiis, M.
    Giuliano, M.
    ESMO OPEN, 2023, 8 (06)
  • [42] Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: A systematic review and meta-analysis
    Schipilliti, F. M.
    Rizzo, A.
    Di Costanzo, F.
    Acquafredda, S.
    Arpino, G.
    Puglisi, F.
    Del Mastro, L.
    Montemurro, F.
    De Laurentiis, M.
    Giuliano, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S289 - S289
  • [43] Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
    Canling Lin
    Jiajun Cui
    Zhen Peng
    Kai Qian
    Runwen Wu
    Yimin Cheng
    Weihua Yin
    European Journal of Medical Research, 27
  • [44] Atezolizumab and pembrolizumab in triple-negative breast cancer: a meta-analysis
    Latif, Farah
    Jabbar, Hira Bint Abdul
    Malik, Hamna
    Sadaf, Humaira
    Sarfraz, Azza
    Sarfraz, Zouina
    Cherrez-Ojeda, Ivan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 229 - 235
  • [45] Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis
    Ma, Xuelei
    Wang, Xiaoshan
    Huang, Jingwen
    Chen, Yingtai
    Zhang, Jing
    Zhang, Binglan
    Shi, Changle
    Liu, Lei
    PLOS ONE, 2016, 11 (08):
  • [46] NEOADJUVANT PLATINUM CONTAINING REGIMEN FOR LOCALLY ADVANCED TRIPLE NEGATIVE BREAST CANCER
    Rahal, M. M.
    Ramadan, H.
    Hassan, E.
    Arini, A.
    Mosleh, H.
    Al Naimy, N.
    Senan, E.
    Abdelwarith, A.
    Al Faraj, A.
    Halawani, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 114 - 115
  • [47] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Jinming Li
    Guoshuang Shen
    Miaozhou Wang
    Xingfa Huo
    Fuxing Zhao
    Dengfeng Ren
    Yi Zhao
    Jiuda Zhao
    Clinical and Experimental Medicine, 2023, 23 : 1489 - 1499
  • [48] Comparative efficacy and safety of first-line neoadjuvant treatments in triple-negative breast cancer: systematic review and network meta-analysis
    Li, Jinming
    Shen, Guoshuang
    Wang, Miaozhou
    Huo, Xingfa
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Yi
    Zhao, Jiuda
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1489 - 1499
  • [49] Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis
    Liu, Zhilin
    Li, Jinming
    Zhao, Fuxing
    Ren, Dengfeng
    Li, Zitao
    Chen, Yongzhi
    Huang, Shifen
    Liu, Zhen
    Zhao, Yi
    Wang, Miaozhou
    Li, Huihui
    Xu, Zhengbo
    Shen, Guoshuang
    Zhao, Jiuda
    BMC CANCER, 2024, 24 (01)
  • [50] Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis
    Cortes, Javier
    Haiderali, Amin
    Huang, Min
    Pan, Wilbur
    Schmid, Peter
    Akers, Katherine G.
    Park, Julie E.
    Frederickson, Andrew M.
    Fasching, Peter A.
    O'Shaughnessy, Joyce
    BMC CANCER, 2023, 23 (01)
12345